drugset / Trial / NCT01638442

Crossover Trial of the Effect of a High-Fat Meal on the PK of Oral CHR 2797 in Healthy Male Subjects

NCT01638442

Phase 1 Completed 18 enrolled CTI BioPharma Chroma Therapeutics · collab
RandomizedCrossoverOpen-labelBasic science

Summary

The objectives of this study are to evaluate the safety and tolerability; and to determine the effect of food on the pharmacokinetics (PK) of CHR-2797 in normal healthy male subjects.

Timeline

Start
2012-06
Primary completion
2012-07
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Tosedostat Small molecule 120 mg Oral

Indications

No indication recorded.